Updated: 2011-09-26 13:51:18
The rate of full genome sequencing has risen by about 1000 in a couple of years. That's because costs have dropped by orders of magnitude. The rapid cost drop looks set to continue. This year, the world's DNA-sequencing machines are expected to churn out 30,000 entire human genomes, according to estimates in Nature magazine. That is up from 2,700 last year and a few dozen in 2009. Recall that merely a decade ago, before the completion of the Human Genome Project, the number was zero. The vast majority of us will be able to afford to get our full genomes sequenced in a few years. Costs are now below $10,000 per genome and in larger quantities below $5,000. What's needed...
Updated: 2011-09-23 13:43:10
Retroransposons, located areas of the genome that have not been thought to have any functional purpose, get transcribed (read from DNA into RNA) in aging stem cells. The resulting RNA fragments mess up the aging stem cells and make them less able to divide and do repair to the body. Some Buck Institute and Georgia Tech researchers have demonstrated accumulated DNA damage with age allows the retrotransposons to interfere with stem cell function. "We demonstrated that we were able to reverse the process of aging for human adult stem cells by intervening with the activity of non-protein coding RNAs originated from genomic regions once dismissed as non-functional 'genomic junk'," said Victoria Lunyak, associate professor at the Buck Institute for Research...
Updated: 2011-09-23 05:01:20
(Beyond Pesticides, September 23, 2011) In two weeks, a diverse coalition of organizations, businesses and individuals will begin to march from the Historic Flatbush Food Co-op in Brooklyn, NY to the gates of the White House to ask the Obama Administration to support labeling of genetically modified organisms (GMOs). The GMO Right2Know March will feature [...]
Updated: 2011-09-20 20:30:50
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-09-20 20:30:48
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-09-20 20:30:45
, Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New
Updated: 2011-09-20 20:30:42
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-09-15 19:41:46
While genetic modification of crops elicits considerable opposition in Europe the opposition is much less in the United States. An Iowa State economist says in a survey he did consumers indicate they would pay more for crops genetic engineered to contain more antioxidants. AMES, Iowa - Consumers are eager to get their hands on, and teeth into, foods that are genetically modified to increase health benefits - and even pay more for the opportunity. A study by Iowa State University researcher Wallace Huffman shows that when consumers are presented with produce enhanced with consumer traits through intragenic means, they will pay significantly more than for plain produce. By "intragenic" they mean genes that are transferred within species. Most of these...
Updated: 2011-09-05 00:40:41
: Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New
